Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non... by Katsuyuki Hotta, Yuka Kato, Natasha Leighl, Nagio Takigawa, Rabab Mohamed Gaafar, Hiroe Kayatani, Taizo Hirata, Kadoaki Ohashi, Toshio Kubo, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura

Get full text

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors by Abdulrahman Alghabban, MD, Lucy Corke, MD, Hans Katzberg, MD, Vera Bril, MD, Carolina Barnett-Tapia, MD, Warren Mason, MD, Raed Alothman, MD, Abdul Razak Albiruni Ryan, MD, David Hogg, MD, Srikala Sridhar, MD, Neesha Dhani, MD, Anna Spreafico, MD, Lawson Eng, MD, Adrian Sacher, MD, Penelope Bradbury, MD, Geoffrey Liu, MD, Natasha Leighl, MD, Frances A. Shepherd, MD

Get full text